Mycobacterium chimaera infection following cardiac surgery in the United Kingdom: clinical features and outcome of the first 30 cases.

[1]  H. Sax,et al.  Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study. , 2017, The Lancet. Infectious diseases.

[2]  M. Pellerin,et al.  Mycobacterium chimaera Infection After Cardiac Surgery: First Canadian Outbreak. , 2017, The Annals of thoracic surgery.

[3]  M. Phillips,et al.  Mycobacterium chimaera left ventricular assist device infections , 2017, Journal of cardiac surgery.

[4]  M. Picard,et al.  Surgical Versus Medical Therapy for Prosthetic Valve Endocarditis: A Meta-Analysis of 32 Studies. , 2017, The Annals of thoracic surgery.

[5]  T. Stinear,et al.  Mycobacterium chimaera Spread from Heating and Cooling Units in Heart Surgery. , 2017, The New England journal of medicine.

[6]  P. Hoffman,et al.  Insidious Risk of Severe Mycobacterium chimaera Infection in Cardiac Surgery Patients , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  C. Curcio,et al.  Clinical and Histopathologic Ocular Findings in Disseminated Mycobacterium chimaera Infection after Cardiothoracic Surgery. , 2017, Ophthalmology.

[8]  M. Strong,et al.  Notes from the Field: Mycobacterium chimaera Contamination of Heater-Cooler Devices Used in Cardiac Surgery - United States. , 2016, MMWR. Morbidity and mortality weekly report.

[9]  G. Guyatt,et al.  Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies , 2016, British Medical Journal.

[10]  A. Badley,et al.  Disseminated Mycobacterium chimaera Infection After Cardiothoracic Surgery , 2016, Open forum infectious diseases.

[11]  T. Eckmanns,et al.  Contamination during production of heater-cooler units by Mycobacterium chimaera potential cause for invasive cardiovascular infections: results of an outbreak investigation in Germany, April 2015 to February 2016. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[12]  E. Blackstone,et al.  Current Hypotheses in Cardiac Surgery: Biofilm in Infective Endocarditis. , 2016, Seminars in thoracic and cardiovascular surgery.

[13]  Thomas R Rogers,et al.  Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study , 2016, The Lancet. Respiratory medicine.

[14]  Susanna Price,et al.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). , 2015, European heart journal.

[15]  Inês João,et al.  General Overview on Nontuberculous Mycobacteria, Biofilms, and Human Infection , 2015, Journal of pathogens.

[16]  V. Falk,et al.  Healthcare-associated prosthetic heart valve, aortic vascular graft, and disseminated Mycobacterium chimaera infections subsequent to open heart surgery. , 2015, European heart journal.

[17]  A. Bolger,et al.  Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association , 2015, Circulation.

[18]  R. Weber,et al.  Prolonged Outbreak of Mycobacterium chimaera Infection After Open-Chest Heart Surgery. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  C. Vassileva,et al.  Long-term Outcomes of Mitral Valve Repair Versus Replacement for Degenerative Disease: A Systematic Review , 2014, Current cardiology reviews.

[20]  Mike Rayner,et al.  Cardiovascular disease statistics 2014 , 2014 .

[21]  B. Hasse,et al.  Prosthetic Valve Endocarditis and Bloodstream Infection Due to Mycobacterium chimaera , 2013, Journal of Clinical Microbiology.

[22]  B. Gazzard,et al.  British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV‐seropositive individuals 2011 , 2011, HIV medicine.

[23]  M. Fariñas,et al.  Clinical course and predictors of death in prosthetic valve endocarditis over a 20-year period. , 2010, The Journal of thoracic and cardiovascular surgery.

[24]  Patricia Muñoz,et al.  Contemporary clinical profile and outcome of prosthetic valve endocarditis. , 2007, JAMA.

[25]  Robert Horsburgh,et al.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.

[26]  R. Appelberg,et al.  Gamma Interferon-Induced T-Cell Loss in Virulent Mycobacterium avium Infection , 2005, Infection and Immunity.

[27]  R. Kroppenstedt,et al.  Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov. , 2004, International journal of systematic and evolutionary microbiology.

[28]  K. Harris,et al.  Development of broad-range 16S rDNA PCR for use in the routine diagnostic clinical microbiology service. , 2003, Journal of medical microbiology.

[29]  J. Kisslo,et al.  Clinical information determines the impact of transesophageal echocardiography on the diagnosis of infective endocarditis by the duke criteria. , 2000, American heart journal.

[30]  V. Fowler,et al.  Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  R. Ansorg,et al.  Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium avium complex. , 1996, Journal of medical microbiology.

[32]  J. Zamorano,et al.  [2015 ESC Guidelines for the management of infective endocarditis]. , 2015, Kardiologia polska.